| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.068 | 0.2 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | 0.096 | 0.2 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.071 | 0.2 |